| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-98 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567 |
| filingDate |
2002-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_244e81965f977646f61b7d1a26a4d51a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55baf5dd0eae2c9c346540a5538dcfab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d85fc23d06424b48bfd4ad3857e0756e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3342cfe8a4c0f48d65985031bc3053 |
| publicationDate |
2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007134732-A1 |
| titleOfInvention |
Lces as modifiers of the p53 pathway and methods of use |
| abstract |
Human LCE genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of LCE are provided. |
| priorityDate |
2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |